We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Gregory Wade is a Managing Director within BTIG Healthcare Investment Banking. He has over 20 years of experience working with entrepreneurs in the biotechnology industry. Prior to BTIG, Dr. Wade was Head of Business Development at Pharmacyclics Inc., where he led the company’s in-licensing activities and contributed to market research, strategy and competitive intelligence efforts. Previously, he spent 15 years in healthcare equity research, most recently as Managing Director at Wedbush PacGrow LifeSciences. Earlier in his career, Dr. Wade held roles in business development at Ionis (Isis) Pharmaceuticals and Procyon BioPharma. He was also an Associate at Helix Investments Canada Inc., while simultaneously undertaking his doctoral research at the University of Western Ontario, where he earned his PhD in physiology and an Honors BS in medical biophysics. Dr. Wade serves on the Investment Committee of Canada’s Healthcare Accelerator, Accel-Rx.
This speaker's sessions: